Fibrobiologics’ CFO Mark Andersen steps down amid corporate upheaval
In a pivotal announcement that has caught both industry insiders and investors by surprise, FibroBiologics, a pioneering name in regenerative medicine, disclosed that Chief Financial Officer Mark Andersen would step down. The resignation, effective November 15, 2024, is reportedly due to his decision to “pursue other opportunities,” marking a critical turning point for the Houston-based […]